Cellectis (CLLS) Net Margin Growth (1y) (2016 - 2026)
Cellectis (CLLS) Net Margin Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,491.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,120.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -653.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 447.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Cellectis | 281.48 Mn | 95.81 Mn | - | 0.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00 |
| Dec 31, 2025 | -4,657.00 |
| Sep 30, 2025 | 14,400.00 |
| Jun 30, 2025 | 17,157.00 |
| Mar 31, 2025 | -12,462.00 |
| Dec 31, 2024 | 1.48 Mn |
| Sep 30, 2024 | 1.11 Mn |
| Jun 30, 2024 | 626,348.00 |
| Mar 31, 2024 | 2.18 Mn |
| Dec 31, 2023 | -1.46 Mn |
| Sep 30, 2023 | 498,815.00 |
| Jun 30, 2023 | -512,739.00 |
| Mar 31, 2023 | -1.97 Mn |
| Dec 31, 2022 | 7,625.00 |
| Sep 30, 2022 | -1.58 Mn |
| Jun 30, 2022 | -109,239.00 |
| Mar 31, 2022 | -187,022.00 |
| Dec 31, 2021 | 5,392.00 |
| Sep 30, 2021 | 4,021.00 |
| Jun 30, 2021 | 75,533.00 |